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The differential diagnosis between hepatocellular carcinoma
(HCC), cholangiocarcinoma (CC) and metastatic colorectal
adenocarcinoma (MCA) may be difficult when only based on
morphology. For this purpose immunohistochemical analyses
are often required, utilizing antibodies directed against CK8-
18, Hep-Par1, glypican 3, CK7, CK19, CK20. Here we report a
case of a 65-year-old man who presented with a clinical pic-
ture of decompensated cirrhosis. Ultrasonography revealed
two nodular areas in the right liver lobe. Liver needle biopsy
revealed micro-macronodular cirrhosis associated with HCC
with trabecular and pseudoglandular patterns. Immuno-
histochemically, tumour cells were diffusely positive for CK8-
18 and also diffusely immunostained by glypican 3 and Hep-
Par1. Interestingly, a diffuse and strong staining for CK20 was
detected in the vast majority of tumor cells, particularly in the
areas showing a pseudo-glandular pattern. No immunostain-
ing for CK7 and CK19 was found in the tumor cells.The tumor
behaved aggressively,with a rapid diffusion  to the whole liver.
The patient died from the disease few months after presenta-
tion. These findings underline that the interpretation of the
expression of CK20 alone in the differential diagnosis among
HCC,CC and MCA should be done with caution because a dif-
fuse immunoreactivity for CK20 alone may not rule out the
diagnosis of HCC.
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T
he differential diagnosis between hepato-
cellular carcinoma (HCC), cholangiocarci-
noma (CC) and metastatic colorectal ade-
nocarcinoma (MCA) may be difficult when only
based on morphology (Terracciano et al., 2003).
In fact, a subset of extrahepatic adenocarcino-
mas of different origin may show a solid “hepa-
toid” pattern virtually indistinguishable from
HCC (Porcell  et al., 2000). On the other hand,
the undifferentiated form of HCC may mimic
poorly differentiated tumors of different origin,
while its tubular and adenoid variants may be
indistinguishable from CC or from MCA.
In these cases, immunohistochemical analyses
are often required (Stroescu et al., 2006).
The panel of antibodies utilized to solve this
differential diagnosis includes: CK8-18 (Porcell
et al., 2000) Hep-Par1 (Leong et al., 1998)
(Zimmerman et al., 2001), glypican 3 (GPC3)
(Yamauchi et al., 2005) (Capurro et al., 2003),
CK7 (Maeda et al., 1996) (Chu et al., 2000),
CK20  (Faa G et al., 1998), CK19, CEA and
Alpha-fetoprotein (Onofre et al., 2007) (Lau et
al., 2002).
Immunoreactivity of tumour cells for CK8-18,
Hep-Par 1 and GPC3 is considered suggestive of
HCC; a diffuse immunoreactivity for CK7 and
CK19 is in favour of the diagnosis of CC; a dif-
fuse positivity for CK20 and negativity for CK7
are normally associated with MCA.
Here we report a case of HCC with a peculiar
immunohistochemical profile, characterized by
the association of the typical immunoreactivity
of HCC with a diffuse and strong positivity for
CK20, generally considered typical of MCA.
BRIEF NOTE
            Materials and Methods
Clinical history
A 65-year-old man was referred to our hospital
because of asthenia and jaundice. On clinical
examination,a picture of decompensated cirrhosis
was evident: edema of the lower extremities,
ascites, palpable spleen. Laboratory tests showed
an increase in serum levels of transaminases (3-4
times normal values), gammaglutamyltranspepti-
dase (3 times normal values),and bilirubin (total:
14.8 mg/dL; conjugated: 9.1 mg/dL).Viral mark-
ers for HBV and HCV were negative.The patient
suffered from alcoholic cirrhosis,diagnosed at the
age of 47. Esophago-gastroduodenoscopy
revealed esophageal varices. Six months before
admission, ultrasonography performed during a
surveillance program detected two hypere-
chogenic space-occupying lesions in the right lobe
of the liver, 3 and 2.4 cm in diameter respectively.
Computed tomography performed three months
later,showed multiple mildly hypodense nodules in
the right liver lobe, with a hypervascular pattern
suggestive of HCC. On admission, liver ultrasound
scan showed a tremendous diffusion of the prolif-
erating nodules throughout the whole liver, with
the tendency to occupy the entire organ. Alpha-
fetoprotein and carcinoembryonic antigen serum
levels were in the normal range. In order to eval-
uate the irregular nodular areas, echo-guided nee-
dle liver biopsy was performed.
Sample preparation
The needle liver biopsy was formalin-fixed,
paraffin-embedded and routinely processed.
Immunohistochemical stainings were performed
using antibodies against CK8-18 (clone 35β H 11
and clone DC 10, Dako Denmark A/S, Glostrup,
Denmark), CK20 (clone K520.8, Dako Denmark
A/S, Glostrup, Denmark), CK7 (clone OV-TL
12/30, Dako Denmark A/S, Glostrup, Denmark),
CK19 (clone RCK 108, Dako Denmark A/S,
Glostrup, Denmark), Hep-Par1 (clone OCH1E5,
Dako Denmark A/S, Glostrup, Denmark) and
GPC3 (clone 1G12, Biomosaic, Inc, Burlington,
VT, USA).
Tissue sections were dewaxed, rehydrated
through graded alcohols and pre-treated with
heat-induced epitope retrieval in 0,01 M Citrate
buffer pH 6.00 (GPC33, Hep-Par1, CK7, CK8
and CK18) or 0,1 M Tris Base/0,01 M EDTA pH
9.00 (CK19 and CK20) for immunohistochemical
analyses. Slides were incubated for 30 minutes at
room temperature with a 1:200 dilution of a poly-
clonal anti GPC3 primary antibody and with 1:50
dilutions of monoclonal antibodies directed
against the following antigens: Hep-Par1, CK7,
CK8, CK18, CK20. Staining procedures were per-
formed by Dako REAL EnVision Detection
System Peroxidase (Dako Denmark A/S,Glostrup,
Denmark) following the manufacturer’s instruc-
tions.
As a control group, we examined the expression
of CK20 in 20 previously diagnosed HCC.
Clinical follow-up
Five months after liver biopsy, the patient devel-
oped hepatic encephalopathy and died.
Results
The histological examination of the liver biopsy
showed two distinct patterns.Silver stain revealed
a completely modified hepatic architecture,due to
the presence of diffuse porto-central bridging
fibrous septa, associated with regenerating hepa-
tocytes arranged in two-cell-thick trabeculae.
Portal tracts and bridging septa often contained a
mild inflammatory infiltrate, with rare foci of
interface hepatitis. Micro and macrovesicular
steatosis was homogeneously distributed through-
out the regenerating nodules.Mallory bodies were
also detected  in the cytoplasm of large hepato-
cytes with clear cytoplasm. Iron deposition was
focally observed in hepatocytes and in Kupffer
cells. In the deeper part of the bioptic core, with
the interposition of a thin fibrous capsule, we
observed the proliferation of neoplastic cells, sim-
ilar in size and shape to hepatocytes, arranged in
two architectural patterns:the trabecular one was
characterized by 3-4 cell-tick trabeculae;the ade-
noid pattern showed smaller cells arranged around
a central lumen (Figure 1). Mitotic figures were
rare. Nuclear vacuoles and pseudoinclusions were
frequently observed. On the basis of the morpho-
logical findings, the diagnosis of micro-macron-
odular cirrhosis with mild activity, compatible
with alcoholic aetiology, complicated by well dif-
ferentiated hepatocellular carcinoma was per-
formed. At immunocytochemistry, the first panel
of antibodies applied evidenced a diffuse
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CK18, and the absence of immunostaining for CK
7 and CK19. Due to the presence of tumor areas
showing an adenoid pattern,with psuedoglandular
arrangement of tumor cells, we also immunos-
tained tumor cells for CK20. The result of the
staining was straightforward: immunoreactivity
for CK20 appeared diffuse in the vast majority of
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Figure 1. Hepatocellular
carcinoma showing a
mixed trabecular and ade-
noid pattern. H&E.
Figure 2. Intense cytoplas-
mic immunoreactivity for
CK20 of the majority of
tumor cells.neoplastic cells.The percentage of CK20-positive
cells ranged from about 50% in areas with tra-
becular features up to 90% in tumor zones show-
ing an adenoid pattern (Figure 2). Given the dis-
crepancy among immunohistochemical data
obtained applying the first panel, we also tested
immunoreactivity of tumor cells for Hep-Par1 and
glypican3.The typical granular cytoplasmic reac-
tivity for Hep-Par1 was found in the vast majori-
ty of tumor cells as well as in the surrounding liver.
The majority of tumor cells were also immunos-
tained by glypican 3, which was completely nega-
tive in the surrounding liver. In the control group,
19 out of 20 previously diagnosed HCCs did not
show any immunoreactivity for CK20, the latter
one evidenced a slight focal positivity in scattered
tumor cells.
Discussion
Although clear criteria for the histological diag-
nosis of HCC have been established by the
International Working Party (1995), the differen-
tial diagnosis of HCC vs CC and MCA may be not
so easy,especially when scant material is available
for histology (Zhu et al.,2001).The report of liver
metastases from adenocarcinomas of extrahepat-
ic origin showing hepatoid features, underlines the
possibility of diagnostic errors when the diagnosis
is only based on morphology (Porcell  et al.,
2000). A report from our group of a striking
intratumoral variability in HCC, related to mor-
phology and to immunoreactivity of tumor cells,
highlights the role of sampling variability as a pos-
sible cause of pitfalls in diagnosing HCC (Senes et
al., 2007). Although poorly differentiated HCC
may lose immunoreactivity for CK8 and CK18
(Van Eyken et al., 1988), HCC is usually CK8
+,
CK18
+,CK 7
–,CK19
–,CK20
– (Chu et al.,2002).In
clinical practice, the use of CK7/CK20 immunos-
taining is considered a useful tool in distinguish-
ing HCC (CK7
+ in 10%; CK20
+ in 7%) from per-
iferal CC (CK7
+ in 96%; CK20
+ in 47%) (Rullier
et al., 2000), non periferal CC (CK7
+ in 96%;
CK20
+ in 82%) (Rullier et al., 2000), colorectal
carcinoma (CK7+ in 27%; CK20
+ 94%) (Chu et
al., 2002), pancreatic cancer (CK7
+ 94%; CK20
+
52%) (Chu et al., 2002) and hepatoblastoma
(CK7
+ 26%) (Chu et al., 2002) (Fiegel et al.,
2004) (Table 1). In normal human tissues, CK20
immunoreactivity is restricted to gastric and
intestinal epithelium (Botta et al., 2000), Merkel
cells of the skin (Miettinen, 1995), and transi-
tional epithelium (Southgate et al.,1999),where-
as it is absent in the liver.In carcinomas,a diffuse
immunoreactivity for CK20 is restricted to a few
tumors: colon cancer (90%), Merkel cell tumor
(86%), transitional cell carcinoma (68%), gas-
tric carcinoma (56%), and pancreatic carcinoma
(56%) (Chu and Weiss, 2002).
Here we report a case of HCC showing an
immunohistochemical pattern normally consid-
ered typical for a metastasis originating from gas-
trointestinal tract primaries (Moll, 1998): a dif-
fuse and strong immunoreactivity of the vast
majority of tumor cells for CK20. In previous
studies CK20 expression has been reported in rare
cases of HCC, always restricted to scattered
tumor cells, and with such a reactivity never cre-
ating diagnostic problems (Maeda et al., 1996).
On the contrary, in our case, the simple applica-
tion of the panel CK7/CK20 could have excluded
the hepatocellular origin of the tumor,in favour of
an hepatoid form of colorectal cancer
(Terracciano  et al., 2003). The reason for this
atypical expression of CK20 in our case is
unknown. Little information is available concern-
ing the factors that regulate the expression of ker-
atin genes in different cell types,in health and dis-
ease (Moll et al., 1982). A study from our group
on CK20 expression in rat liver demonstrated a
strong proliferation of CK20
+ cells following an
experimentally induced cholestasis (Faa et al.,
1998), showing that keratin expression patterns
do not necessarily reflect histogenesis,but may be
influenced even by epigenetic factors.
From a practical point of view, the present case
confirms previous reports on the complexity of
making an unequivocal diagnosis of HCC. The
possibility of negativity of small HCCs for Hep-
Par 1 (Sugiki et al., 2004), the patchy expression
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Table 1. CK7/CK20 immunostaining.
CK 7 CK 20
HCC 10% 7%
Periferal CC 96% 47%
Non periferal CC 96% 82%
Colorectal carcinoma 27% 94%
Pancreatic cancer 94% 52%
Hepatoblastoma 26% n.a.273
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of CK8-18 (Van Eyken P et al.,1988),the uneven
distribution of GPC-3 (Yamauchi et al., 2005)
(Capurro et al., 2003) suggest the possibility of
sampling errors and recommend that caution
should be taken in the interpretation of immuno-
histochemical data concerning HCC.
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